ZA949593B - N-substituted azabicycloheptane derivatives their preparation and use - Google Patents

N-substituted azabicycloheptane derivatives their preparation and use

Info

Publication number
ZA949593B
ZA949593B ZA949593A ZA949593A ZA949593B ZA 949593 B ZA949593 B ZA 949593B ZA 949593 A ZA949593 A ZA 949593A ZA 949593 A ZA949593 A ZA 949593A ZA 949593 B ZA949593 B ZA 949593B
Authority
ZA
South Africa
Prior art keywords
preparation
pct
azabicycloheptane derivatives
substituted azabicycloheptane
sec
Prior art date
Application number
ZA949593A
Other languages
English (en)
Inventor
Gerd Steiner
Rainer Munschauer
Liliane Unger
Hans-Juergen Teschendorf
Thomas Hoeger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA949593B publication Critical patent/ZA949593B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ZA949593A 1993-12-04 1994-12-02 N-substituted azabicycloheptane derivatives their preparation and use ZA949593B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341402A DE4341402A1 (de) 1993-12-04 1993-12-04 N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ZA949593B true ZA949593B (en) 1996-06-03

Family

ID=6504204

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949593A ZA949593B (en) 1993-12-04 1994-12-02 N-substituted azabicycloheptane derivatives their preparation and use

Country Status (22)

Country Link
US (1) US5616705A (xx)
EP (1) EP0740658B1 (xx)
JP (1) JP3883567B2 (xx)
KR (1) KR100331407B1 (xx)
CN (1) CN1054844C (xx)
AT (1) ATE244222T1 (xx)
AU (1) AU679812B2 (xx)
BR (1) BR9408244A (xx)
DE (2) DE4341402A1 (xx)
ES (1) ES2202348T3 (xx)
FI (1) FI962323A (xx)
HR (1) HRP940960A2 (xx)
HU (1) HU220070B (xx)
IL (1) IL111862A (xx)
NO (1) NO306400B1 (xx)
NZ (1) NZ276411A (xx)
PL (1) PL314840A1 (xx)
RU (1) RU2136678C1 (xx)
TW (1) TW324007B (xx)
UA (1) UA44721C2 (xx)
WO (1) WO1995015312A1 (xx)
ZA (1) ZA949593B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
SI20638A (sl) 1998-07-17 2002-02-28 Agouron Pharmaceuticals, Inc. Spojine, sestavki in metode za stimulacijo rasti in podaljševanja nevronov
DE19836404A1 (de) * 1998-08-12 2000-02-17 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE19836406A1 (de) * 1998-08-12 2000-02-17 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US6458821B1 (en) 1998-08-12 2002-10-01 Abbott Laboratories N-substituted azabicycloheptane derivatives, production and use thereof
FR2791345B1 (fr) * 1999-03-26 2001-05-04 Adir Nouveaux derives du benzo[3,4]cyclobuta[1,2-c]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA05001726A (es) * 2002-08-14 2005-05-27 Abbott Lab Compuestos azabiciclicos son agentes activos del sistema nervioso central.
US7135484B2 (en) 2002-08-14 2006-11-14 Abbott Laboratories Azabicyclic compounds are central nervous system active agents
ATE423769T1 (de) * 2002-08-23 2009-03-15 Ranbaxy Lab Ltd Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten
FR2953514B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives azabicyclo[3.2.0]hept-3-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US10233191B2 (en) 2013-07-10 2019-03-19 Vertex Pharmaceuticals Incorporated Fused piperidine amides as modulators of ion channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4112353A1 (de) * 1991-04-16 1992-10-22 Basf Ag 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
JP3883567B2 (ja) 2007-02-21
BR9408244A (pt) 1997-05-27
CN1136807A (zh) 1996-11-27
HU9601511D0 (en) 1996-07-29
UA44721C2 (uk) 2002-03-15
EP0740658A1 (de) 1996-11-06
FI962323A0 (fi) 1996-06-03
EP0740658B1 (de) 2003-07-02
AU679812B2 (en) 1997-07-10
HRP940960A2 (en) 1997-10-31
ES2202348T3 (es) 2004-04-01
RU2136678C1 (ru) 1999-09-10
KR100331407B1 (ko) 2002-12-05
IL111862A (en) 1999-03-12
HU220070B (hu) 2001-10-28
NO306400B1 (no) 1999-11-01
CN1054844C (zh) 2000-07-26
HUT75315A (en) 1997-05-28
ATE244222T1 (de) 2003-07-15
JPH09505820A (ja) 1997-06-10
NZ276411A (en) 1997-11-24
US5616705A (en) 1997-04-01
TW324007B (en) 1998-01-01
DE4341402A1 (de) 1995-06-08
NO962285D0 (no) 1996-06-03
AU1067195A (en) 1995-06-19
NO962285L (no) 1996-06-03
WO1995015312A1 (de) 1995-06-08
FI962323A (fi) 1996-06-03
PL314840A1 (en) 1996-09-30
IL111862A0 (en) 1995-03-15
DE59410304D1 (de) 2003-08-07

Similar Documents

Publication Publication Date Title
IL111861A0 (en) N-substituted azabicycloalkane derivatives
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
ZW8594A1 (en) Substituted azadioxacycbalkenes
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
TW261614B (xx)
HRP950437B1 (en) N-substituted azabicycloheptane derivatives, their production and use
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
PL311296A1 (en) Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents
PL309339A1 (en) Novel triazoquinazolines, methods of obtaining them and their application